DR. Chip Biotechnology Incorporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 12.66 million compared to TWD 11.51 million a year ago. Net loss was TWD 15.21 million compared to TWD 9.94 million a year ago. Basic loss per share from continuing operations was TWD 0.39 compared to TWD 0.52 a year ago. Diluted loss per share from continuing operations was TWD 0.39 compared to TWD 0.52 a year ago.
For the six months, sales was TWD 32.39 million compared to TWD 40.33 million a year ago. Net loss was TWD 24.75 million compared to TWD 13.88 million a year ago. Basic loss per share from continuing operations was TWD 0.82 compared to TWD 0.73 a year ago. Diluted loss per share from continuing operations was TWD 0.82 compared to TWD 0.73 a year ago.